潜伏性结核感染治疗中γ干扰素释放试验结果的动态变化
该随机对照研究纳入910例接受8周每周一次利福喷汀联合异烟肼治疗者、890例接受6周每周两次利福喷汀联合异烟肼治疗者和818例未治疗对照,随访2年。结果发现三组QFT-GIT持续逆转率相似(19.0%、18.5%、20.7%,p=0.512),IFN-γ水平动态变化无统计学差异。结论认为QFT-GIT逆转或IFN-γ水平下降不能用于监测潜伏性结核感染治疗反应。
要点
- QFT-GIT逆转率在治疗组与未治疗对照组间无显著差异(p=0.512)。
- 治疗者中基线IFN-γ较高者结核发生率高于较低者(1.0% vs 0.2%,p=0.037)。
- QFT-GIT逆转或IFN-γ下降不宜用于监测潜伏性结核感染治疗反应。
核心结论
- QFT-GIT逆转或IFN-γ水平下降不应作为监测潜伏性结核感染治疗宿主反应的指标。
研究设计与样本
- 随机对照研究,共纳入910例接受8周每周一次利福喷汀联合异烟肼治疗者(A组)、890例接受6周每周两次利福喷汀联合异烟肼治疗者(B组)和818例未治疗对照(C组),随访2年。
主要发现
- QFT-GIT持续逆转率在A组为19.0%(173/910)、B组为18.5%(165/890)、C组为20.7%(169/818),三组间p=0.512。
- 三组间IFN-γ水平的动态变化无统计学显著性差异。
- 在治疗参与者中,基线IFN-γ水平较高者结核发生率(1.0%,9/896)高于基线水平较低者(0.2%,2/904),p=0.037。
- 在未治疗对照中观察到类似趋势但无统计学显著性(1.8%(7/400)vs 0.5%(2/418),p=0.100)。
- 将结核病例与非结核病例按基线IFN-γ水平匹配后,无论是否接受治疗,IFN-γ水平随时间的动态变化均无显著差异。
临床怎么用
- 临床不应使用QFT-GIT逆转或IFN-γ水平下降来评估潜伏性结核感染治疗是否有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Using QuantiFERON-TB Gold In-Tube (QFT-GIT) for monitoring tuberculosis (TB) and latent TB infection treatment effect is controversial. The present study aimed to evaluate the dynamic changes of interferon gamma (IFN-γ) levels along with latent TB infection treatment via a randomized controlled study. METHODS: A total of 910 participants treated with 8 weeks of once-weekly rifapentine plus isoniazid (group A), 890 treated with 6 weeks of twice-weekly rifapentine plus isoniazid (group B) and 818 untreated controls (group C) were followed for 2 years to track active TB development. QFT-GIT tests were repeated three times for all groups: before treatment (T0), at completion of treatment (T1) and 3 months after completion of treatment (T2). RESULTS: Similar rates of persistent QFT-GIT reversion were observed in groups A (19.0%, 173/910), B (18.5%, 165/890) and C (20.7%, 169/818) (p 0.512). The dynamic changes of IFN-γ levels were not statistically significant among the three groups. In treated participants, individuals with higher baseline IFN-γ levels showed increased TB occurrence (1.0%, 9/896) compared to those with lower baseline levels (0.2%, 2/904) (p 0.037). A similar but statistically insignificant trend was also observed in untreated controls (1.8% (7/400) vs. 0.5% (2/418), p 0.100). When TB cases were matched with non-TB cases on baseline IFN-γ levels, no significant differences were found with respect to the dynamic changes in IFN-γ levels with time, regardless of whether they received treatment. CONCLUSIONS: QFT-GIT reversion or decreased IFN-γ levels should not be used for monitoring host response to latent TB infection treatment.
引用
- Xin H, Cao X, Zhang H, et al. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment. Clin Microbiol Infect. 2020. PMID: 32062048. doi:10.1016/j.cmi.2020.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。